Glenmark Pharma share price falls over 6% as Nirma agrees to buy 75% stake in subsidiary Glenmark Life Sciences
Glenmark Pharma share price falls over 5 per cent as Nirma agrees to buy a 75 per cent stake in subsidiary Glenmark Life Sciences.
Glenmark Pharma share price declined over 6 per cent in early trade on BSE on Friday (September 22) as investors digested the latest reports of Nirma buying a 75 per cent stake in its subsidiary Glenmark Life Sciences. The stock opened at ₹815.95 against the previous close of ₹828.05 and fell 6.30 per cent to the level of ₹775.85 on BSE in today's trade so far.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started